Project Grant R01MH139372
- The National Institute of Mental Health awarded the Research Foundation For Mental Hygiene, Inc. (operating as New York State Psychiatric Institute) $1.248 million on August 7, 2026, under the Mental Health Research Grants program (CFDA 93.242) to implement evidence-based early intervention services for young people with untreated psychosis in Mozambique. The project, titled Mental Wellness Coordinated Specialty Care (MWELL-CSC) in Mozambique, develops and deploys a patient-centered digital...
- The National Institute of Mental Health awarded the University of Alabama at Birmingham $678,550 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a randomized clinical trial evaluating the Advanced HIV Re-engagement in Care (ARC) intervention in Zambia. ARC is a package of evidence-based, theory-informed elements delivered by supervised community health workers during hospitalization and the post-discharge period to improve outcomes for people with...
- The National Institute of Mental Health awarded the University of Washington $699,750 on May 7, 2026, under the Mental Health Research Grants program (CFDA 93.242) to adapt and evaluate the "Do More, Feel Better" behavioral activation intervention for older people living with HIV who experience depression and have limited access to professional mental health care. The project addresses a documented gap: older people living with HIV (age 50 and above) represent more than half of the...
- The National Institute of Mental Health awarded the University of Washington $613,244 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a cluster randomized controlled trial addressing food insecurity and HIV outcomes among women living with HIV in Senegal. The research leverages agriculture and community engagement to improve HIV care outcomes in the Casamance region of southern Senegal, the area most severely affected by the HIV epidemic and facing the...
- The National Institute of Mental Health awarded RTI International $1,553,132 on May 6, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a hierarchical factorial cluster-randomized controlled trial evaluating a multilevel intervention to reduce stigma among women living with HIV in Tanzania. The study addresses gaps in evidence-based, multilevel stigma reduction interventions designed to improve sustained engagement in HIV care and achieve durable viral...
- The National Institute of Mental Health awarded the University of Texas at Austin $171,793 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and test an interactive mobile health chatbot (IPC Trainer) designed to improve the cost-effectiveness and quality of interpersonal counseling delivery by non-specialists treating common mental disorders in community settings in Mozambique. The project addresses two persistent challenges in task-shifted mental...
- The National Institute of Mental Health awarded Duke University $508,072 on May 18, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a hybrid type-2 effectiveness-implementation trial testing the integration of Sauti Ya Vijana (SYV, the Voice of Youth), a peer-led, group-based mental health treatment, within HIV clinical care for youth living with HIV in Tanzania and the United States. The award funds research designed to address the mental health treatment gap...
- The National Institute of Mental Health awarded Miresource, Inc. $1.744 million on September 12, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop a longitudinal mental health monitoring platform that generates personalized care guides and treatment referrals. Miresource will integrate software solutions, curate mental health content, and employ artificial intelligence to create personalized guides and automate triage and referral recommendations. The project aims to...
- The National Institute of Mental Health awarded the University of Rochester $446,515 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and test LAFIYA Pharmacy, a multilevel intervention combining an evidence-based U.S. pharmacy HIV prevention delivery model with behavioral components designed to expand access to HIV testing and oral or long-acting injectable HIV prevention medication through community pharmacies in Ghana. The intervention targets men...
- The National Institute of Mental Health awarded the University of North Carolina at Chapel Hill $1,454,676 on August 7, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a randomized controlled trial of problem-solving therapy (PST) to improve common mental disorder and HIV care outcomes for people with HIV on antiretroviral therapy in Vietnam. The study tests a task-shifted, non-specialist-delivered mental health intervention designed to address the gap between...
The National Institute of Mental Health awarded The Rand Corporation $676,820 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to evaluate the decentralization and scale-up of integrated chronic care clinics in Malawi. The award funds a stepped-wedge cluster randomized trial that would permanently transition Malawi's HIV delivery platform—a network of 700 clinics serving over 900,000 clients—into full-time integrated chronic care facilities providing daily services for HIV, major depressive disorder, generalized anxiety disorder, hypertension, and type-2 diabetes to adolescents ages 15 and older and adults. The trial builds on prior research demonstrating the effectiveness of a mobile clinic model and is designed to scale integrated services from approximately 14,000 to 120,000 people, offering district-wide coverage. The project brings together leading experts on mental health, non-communicable diseases, and HIV service delivery from top U.S. and Malawian institutions, including the Malawian Ministry of Health. The period of performance extends from September 1, 2026, to May 31, 2031. Place of performance is Arlington, Virginia.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $676.8k | 8/18/26 |